SCHEMBL1294840

SCHEMBL1294840

CCOC(=O)CCc1cc2c(cc1I)CCC(=O)N2

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 3/20 0.42
▸ GAA P10253 2/20 0.42
▸ CYP4F2 P78329 2/20 0.40
▸ CYP4A11 Q02928 2/20 0.40
▸ DRD2 P14416 1/20 0.39
▸ CYP19A1 P11511 1/20 0.39
▸ CYP11B1 P15538 1/20 0.39
▸ CYP11B2 P19099 1/20 0.39
▸ MAPT P10636 2/20 0.38
▸ HPGD P15428 2/20 0.38
▸ HSD17B10 Q99714 2/20 0.38
▸ MAPK1 P28482 1/20 0.38
▸ KDM4E B2RXH2 2/20 0.37
▸ BRD4 O60885 1/20 0.37
▸ PDE3B Q13370 2/20 0.36
▸ PDE3A Q14432 2/20 0.36
▸ CRBN Q96SW2 2/20 0.36
▸ MAOA P21397 2/20 0.35
▸ MAOB P27338 2/20 0.35
▸ P2RY12 Q9H244 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18648483 0.88 ALDH1A1 (0.43) ALDH1A1GAACYP4F2CYP4A11DRD2
SCHEMBL1294634 0.82 CA9 (0.39) CYP19A1CYP11B1CYP11B2BRD4CRBN
SCHEMBL14562688 0.78 HDAC3 (0.38) ALDH1A1GAABRD4CRBNMAOA
SCHEMBL11770569 0.75 MAOA (0.47) ALDH1A1DRD2MAPTMAPK1KDM4E
SCHEMBL10646898 0.74 ALDH1A1 (0.54) ALDH1A1GAACYP4F2CYP4A11DRD2
SCHEMBL15828392 0.74 CYP4F2 (0.41) ALDH1A1GAACYP4F2CYP4A11MAPT
SCHEMBL14641744 0.74 CA9 (0.39) DRD2CYP19A1CYP11B1CYP11B2BRD4
SCHEMBL12110597 0.74 NQO2 (0.43) ALDH1A1DRD2BRD4CRBN
SCHEMBL12110181 0.74 ALDH1A1 (0.35) ALDH1A1GAACYP4F2CYP4A11DRD2
SCHEMBL1294737 0.73 MAOA (0.33) BRD4CRBNMAOAMAOB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9598434-B2 Benzazepine compound ASTELLAS PHARMA INC. (JP) 2017-03-21 — — US disclosed
US-9598434-B2 Benzazepine compound ASTELLAS PHARMA INC. (JP) 2017-03-21 — — US disclosed
US-20150315208-A1 BENZAZEPINE COMPOUND ASTELLAS PHARMA INC. (JP) 2015-11-05 — — US disclosed
US-20150315208-A1 BENZAZEPINE COMPOUND ASTELLAS PHARMA INC. (JP) 2015-11-05 — — US disclosed
US-9108977-B2 Benzazepine compound ASTELLAS PHARMA INC. (JP) 2015-08-18 — — US disclosed
US-9108977-B2 Benzazepine compound ASTELLAS PHARMA INC. (JP) 2015-08-18 — — US disclosed
US-20130059837-A1 BENZAZEPINE COMPOUND ASTELLAS PHARMA INC. (JP) 2013-03-07 — — US disclosed
US-20130059837-A1 BENZAZEPINE COMPOUND ASTELLAS PHARMA INC. (JP) 2013-03-07 — — US disclosed
EP-2546255-A1 BENZAZEPINE COMPOUND Astellas Pharma Inc. (JP) 2013-01-16 — — EP disclosed
US-20130012496-A1 BENZAZEPINE COMPOUND ASTELLAS PHARMA INC. (JP) 2013-01-10 — — US disclosed
US-20130012496-A1 BENZAZEPINE COMPOUND ASTELLAS PHARMA INC. (JP) 2013-01-10 — — US disclosed
CN-102869665-A Benzazepine Compounds ASTELLAS PHARMA INC 2013-01-09 — — CN disclosed
US-20110269744-A1 Benzazepine Compound ASTELLAS PHARMA INC. (JP) 2011-11-03 — — US disclosed
US-20110269744-A1 Benzazepine Compound ASTELLAS PHARMA INC. (JP) 2011-11-03 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130012496-A1 BENZAZEPINE COMPOUND HTR2C, HTR2A, HTR3C ALDH1A1 1373/4885GAA 2099/4885CYP4F2 2917/4885
US-20110269744-A1 Benzazepine Compound HTR2C, HTR3C, HTR2A ALDH1A1 1136/4885GAA 1573/4885CYP4F2 2795/4885
US-20130059837-A1 BENZAZEPINE COMPOUND HTR2C, HTR2A, HTR3C ALDH1A1 1373/4885GAA 2099/4885CYP4F2 2917/4885
US-20150315208-A1 BENZAZEPINE COMPOUND HTR2C, HTR2A, HTR3C ALDH1A1 1373/4885GAA 2099/4885CYP4F2 2917/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback